# HPV Vaccine Impact: Cervical Cancer Prevention

Visualizing the global success and inequity of HPV vaccination programs in preventing cervical cancer (2006-2024).

87% reduction in cervical cancer rates in vaccinated cohorts, yet 90% of deaths occur in low/middle-income countries with limited vaccine access.

### Visual Encoding

Circle Size / 3D Height:
Circle Color:

### Global Impact

Countries with Programs 146
Avg Coverage (Global) 48%
High-Income Coverage 84%
Low-Income Coverage 27%
Potential Lives Saved/Year 311K

### Vaccine Timeline

2006 First HPV vaccine approved (Gardasil)
2009 20 countries adopt national programs
2014 WHO recommends HPV vaccination
2019 100+ countries with programs
2024 146 countries, but coverage gaps persist

### Legend

Color Scale: Cervical Cancer Incidence
Low (2 per 100K) High (44 per 100K)
Size/Height: HPV Vaccine Coverage
0% (No program) 95% (High coverage)

#### Gender Equity & Health Justice

Cervical cancer is almost entirely preventable through HPV vaccination, yet remains the 4th most common cancer in women globally.

Health Inequity: High-income countries achieve 80%+ coverage while low-income countries struggle below 30%, perpetuating preventable deaths among the world's most vulnerable women.
3D Visualization Mode: When 3D cancer burden is enabled, column heights represent annual cervical cancer deaths. Taller columns indicate higher death burden, visualizing the devastating impact in regions with low vaccine coverage.